Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ Aug 06, 2015
A process for control of particle size distribution of active pharmaceutical ingredients
Read more
Scientific Article
/ Apr 01, 2015
Microparticles, preparation and purification methods, molecularly imprinted polymer layer, pharmaceuticals
Read more
Scientific Article